Novel N-aminoalkyldibenzothiopencarboxamide receptor subtype specific ligands
AssigneeNeurogen Corporation
InventorsJun Yuan, Xi Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeurogen Corporation
InventorsJun Yuan, Xi Chen
Estimating the term…
Disclosed are compounds of the formula: 1 or the pharmaceutically acceptable acid addition salts thereof, wherein: R1, R2, R3, R4 are the same or different and represent hydrogen, C1-C6 alkyl, halogen, hydroxy, amino, cyano, nitro, trifluoromethyl, trifluoromethoxy, C1-C6 alkoxy, —O2CR′, —NHCOR′, —COR′, —SOmR′, where R′ is C1-C6 alkyl and wherein m is 0, 1 or 2; or R1, R2, R3, R4 independently represent —CONR′R″, or —NR′R″ where R′ and R″ independently represent hydrogen or C1-C6 alkyl; R5 is hydrogen or C1-C6 alkyl; and R represents an aminoalkyl group, which compounds are useful in the treatment of affective disorders such as schizophrenia, depression, Alzheimer's disease, movement disorders such as Parkinsonism and dystonia, and other disorders which respond to dopaminergic blockade such as substance abuse and obsessive compulsive disorders. Further, compounds of this invention may be useful in treating the extrapyramidal side effects associated with the use of conventional neuroleptic agents.
A compound of the formula:
A compound of the formula:
A compound of the formula:
Dependencies are inferred from the claim text.